With the aging world population, more and more people with chronic diseases need health care. According to World Health Organization (WHO) reports, chronic diseases including cardiovascular diseases, cancers, respiratory diseases and diabetes are responsible for 63% of all deaths in the world. It is estimated that this rate will increase even more due to reasons such as obesity, inactivity, malnutrition, intense stress, increased consumption of alcohol and cigarettes.

Compounding these difficulties, the COVID-19 pandemic has revealed how vulnerable the health sector is to change. Health care has reached a point of critical importance like never before. It became clear that no health system is safe from the “next big thing”. In order for health services to survive, the necessity of constantly innovating to produce groundbreaking products, services and solutions has been recognized by all circles.

The main challenge that the health sector is facing around the world today that must be overcome is increasing quality without compromising human health while working with shrinking budgets and rising costs. While costs have continued to rise over the last two decades, revenues have tended to fall. The establishment of business models and corporate structures that will provide the strategic transformation required to overcome this challenge is also critical to the future of the health sector. As a result, we established Baymed within the Haskan Group of Companies.